ArticleScientific reports2026
Chemical composition, antioxidant and antimicrobial activities, and molecular docking of Acacia gerrardii leaf extract.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacokinetic and phytochemical screening of Allium subhirsutum leaves for antimicrobial and anti-inflammatory properties.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aims to investigate the chemical composition, mineral content, antimicrobial and antioxidant activities, and pharmacokinetic properties of the methanolic extract of Acacia gerrardii leaves. Mineral analysis using ICP-AES revealed iron as the predominant element (6.67 mg/g), followed by aluminum (4.70 mg/g) and trace elements such as zinc (13.18 µg/g), silver (11.24 µg/g) and selenium (134.073 µg/g). Chemical profiling demonstrated the extract's richness in phenolic compounds (316.61 mg GAE/g) and flavonoids (11.17 ± 1.76 mg QE/g extract). LC-MS analysis identified major flavonoid constituents, while GC-MS revealed key components such as 4-O-methylmannose (73.83%) and linolenic acid (2.91%). The antimicrobial assays revealed concentration-dependent activity, with the highest inhibition zones (15.33 ± 0.57 mm) observed against Klebsiella pneumoniae at 3 mg/disc. The extract exhibited bacteriostatic effects against most bacterial strains and fungicidal properties against Candida species. Antioxidant evaluation showed significant activity, with IC₅₀ values of 0.28 mg/mL (DPPH) and 63.63 mg/mL (FRAP). Computational analyses affirmed the druglikeness of the phytochemicals, with most adhering to Lipinski's rule and exhibiting favorable bioavailability and pharmacokinetic profiles. Molecular docking highlighted strong binding affinities (- 10.4 kcal/mol) of specific compounds to microbial protein targets, suggesting their potential as antimicrobial agents. These findings underscore the pharmacological promise of A. gerrardii, particularly its antioxidant and antimicrobial properties linked to its phytochemical composition. Future research should explore the bioactivities of individual compounds in vivo and assess their therapeutic applications. This study enriches the understanding of A. gerrardii and highlights its potential as a resource for novel bioactive agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.